# The Hartford Insurance Group, Inc. (HIG)

> Source: Nexqual · https://nexqual.com/HIG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, The Hartford Insurance Group, Inc. (HIG), nexqual.com/HIG" · informational, not investment advice.

**Price:** USD 139.45 (+2.67% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 135.82 · day 136.4–139.72 · 52w 120.33–146.07 · market cap $37.8B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $29.1B, net income $4.37B (15.0% margin), free cash flow $5.87B (SEC filings).
- Valuation: P/E 8.7x (avg 10.3x at the last 3 fiscal year-ends), net debt $4.17B.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $1.2M; 0 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 1 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 2.58 on a 1–5 scale) (24 analysts), mean target USD 146.86 (range 135–163).
- Total return with dividends: 1Y +13.3% vs S&P 500 +14.9%; 5Y +107.9% vs S&P 500 +80.3%.
- Next earnings: 2026-10-26, EPS estimate USD 3.17, revenue estimate $7.41B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $22.4B | $22.4B | $24.5B | $26.5B | $28.4B | $29.1B |
| Net income | $2.37B | $1.82B | $2.50B | $3.11B | $3.84B | $4.37B |
| EPS (diluted) | $6.64 | $5.46 | $7.97 | $10.35 | $13.32 | — |
| Free cash flow | $3.96B | $3.83B | $4.00B | $5.76B | $5.75B | $5.87B |
| Net margin | 10.6% | 8.1% | 10.2% | 11.7% | 13.5% | 15.0% |
| Revenue growth | +9.1% | -0.1% | +9.7% | +8.2% | +6.9% | — |
| Cash + short-term investments | $337M | $344M | $189M | $234M | $166M | — |
| Total debt | $4.94B | $4.36B | $4.36B | $4.37B | $4.37B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 8.7x · P/S 1.3x · EV/Sales 1.4x · P/FCF 6.4x · P/B 1.9x · FCF yield 15.55% · Earnings yield 11.56% · Dividend yield (paid, TTM) 1.65% · Buyback yield (TTM) 4.54% · Net debt $4.17B · EV $41.9B
P/E at fiscal year-ends: Dec 2025 10.3x, Dec 2024 10.5x, Dec 2023 10.0x.

## Insider sales (SEC Form 4, open-market, last ~7 months)
1 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Tooker Adin M | President | 8,895 | $1.2M | 18.9% | Yes | Routine (sold in Feb each year 2023–2025; this trade is outside those months) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Hold (mean 2.58 on a 1–5 scale), 24 analysts; mean target USD 146.86 (low 135, high 163).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Keefe, Bruyette & Woods | Target lowered | Market Perform | $144 → $137 |
| 2026-10-12 | Wells Fargo | Target lowered | Overweight | $164 → $158 |
| 2026-10-12 | Truist Securities | Initiated | Hold | $137 |
| 2026-10-07 | Mizuho | Target lowered | Neutral | $154 → $144 |
| 2026-10-07 | Cantor Fitzgerald | Target raised | Overweight | $144 → $145 |
| 2026-10-06 | Morgan Stanley | Target lowered | Equal-Weight | $145 → $135 |
| 2026-10-06 | UBS | Target lowered | Buy | $155 → $149 |
| 2026-09-16 | Mizuho | Downgrade | Outperform → Neutral | $163 → $154 |
| 2026-07-28 | Keefe, Bruyette & Woods | Target raised | Market Perform | $143 → $144 |
| 2026-07-27 | RBC Capital | Target raised | Sector Perform | $145 → $150 |
| 2026-07-27 | Wells Fargo | Target lowered | Overweight | $165 → $164 |
| 2026-07-20 | JP Morgan | Target raised | Neutral | $149 → $152 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +13.3% | +107.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +13.4% | +15.7% |
| Volatility (annualized) | 19.7% | 20.7% |
| Max drawdown | -15.6% (Jul 2026→Sep 2026) | -16.4% (Apr 2022→Sep 2022) |

## Peers (Insurance - Diversified)
ACGL (Arch Capital Group Ltd.) USD 102.69 +2.40% · AIG (American International Group, I) USD 83.03 +1.57% · SLF (Sun Life Financial Inc.) USD 80.81 +0.12% · AEG (Aegon Ltd. New York Registry Sh) USD 8.21 -2.15% · BNT (Brookfield Wealth Solutions Ltd) USD 38.26 +2.05% · PLGO (Pelagos Insurance Capital Limit) USD 26.21 +2.26%

## More
Full page: https://nexqual.com/HIG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in HIG's own 10-K filed 2026-02-20 (https://www.sec.gov/Archives/edgar/data/874766/000087476626000012/hig-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | BERKSHIRE HATHAWAY INC (BRK-B) | "The Company has an adverse development cover reinsurance agreement with NICO, a subsidiary of Berkshire Hathaway Inc., to reinsure loss development after 2016 on substantially all of the Company's asbestos and environmen…" |

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| P&C Business Insurance | $4.24B | 58.4% | +9.8% |
| Employee Benefits | $1.91B | 26.3% | +8.4% |
| P&C Personal Insurance | $1.01B | 13.9% | -0.9% |
| Property & Casualty Other Operations | $23.0M | 0.3% | +35.3% |
| Total revenue | $7.26B | 100% | — |

## Company outlook (8-K filed 2026-07-23)

- "Loss ratio of 72.5 increased from 69.1 in second quarter 2025. • Group life loss ratio of 74.2 was relatively consistent with 2025 at 74.3. • Group disability loss ratio of 74.8 increased 6.3 points from 68.5 driven by increased claim incidence across short and long-term disability products and less favorable long-term disability claim recoveries although in line with long-term expectations."
- "Preferred stock dividends are a cost of financing more akin to interest expense on debt and are expected to be a recurring expense as long as the preferred stock is outstanding. 15 Net income (loss) and net income (loss) available to common stockholders are the most directly comparable U.S."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $3.17 | $3.08 | +3.1% | $7.41B | 23 |
| Next quarter (ends 2026-12-31) | $3.25 | $3.22 | +0.9% | $7.25B | 21 |
| Current fiscal year (ends 2026-12-31) | $12.94 | $12.63 | +2.5% | $28.92B | 13 |
| Next fiscal year (ends 2027-12-31) | $13.78 | $13.84 | -0.4% | $29.98B | 24 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-26): ±5.8%; last 8 reports averaged ±2.2%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 25.5% | ±5.8% |
| 2026-12-18 | 56 | 22.1% | ±7.0% |
| 2027-03-19 | 147 | 21.5% | ±10.9% |
| 2027-06-17 | 237 | 22.3% | ±14.3% |